1. Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells
    Xianqi Zhao et al, 2015, Viruses CrossRef
  2. Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen
    Sugandha Bhatia et al, 2020, Cancers CrossRef
  3. Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
    Yali Fan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  4. The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
    Hongmei Cui et al, 2021, Frontiers in Pharmacology CrossRef
  5. The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis
    null Bregenzer et al, 2019, Cancers CrossRef
  6. SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients
    Usama Khamis Hussein et al, 2021, Biomolecules CrossRef
  7. RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer
    Gwan Hee Han et al, 2022, The Journal of Gene Medicine CrossRef
  8. Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
    Qing-Quan Li et al, 2009, Clinical Cancer Research CrossRef
  9. Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial
    Fatéméh Dubois et al, 2019, Cancers CrossRef
  10. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC
    Kathrin Böpple et al, 2024, Cell Death & Disease CrossRef
  11. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology
    Athina A. Kyriazi et al, 2020, International Journal of Molecular Sciences CrossRef
  12. Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
    Amy H. Lee et al, 2022, Cancers CrossRef
  13. The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
    Jihye Seo et al, 2021, Archives of Pharmacal Research CrossRef
  14. Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
    Andrew Sulaiman et al, 2021, Biomedicines CrossRef
  15. Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells
    Fei Zhang et al, 2015, International Journal of Molecular Sciences CrossRef
  16. Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
    Robert Cornelison et al, 2017, International Journal of Molecular Sciences CrossRef
  17. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
    Antonio Hrvat et al, 2024, Frontiers in Immunology CrossRef
  18. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
    Tze-Sian Chan et al, 2019, Frontiers in Oncology CrossRef
  19. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
    Masahiro Uehara et al, 2024, Cancer Drug Resistance CrossRef
  20. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells
    Yi Yang et al, 2016, International Journal of Molecular Sciences CrossRef
  21. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
    Malihe Rezaee et al, 2023, Frontiers in Pharmacology CrossRef
  22. Ginsenoside Re Suppress the Proliferation and Migration of MCF-7 Human Breast Cancer Cells
    Jin-Nyoung Ho, 2024, Journal of the Korean Society of Food Science and Nutrition CrossRef
  23. Targeting Metastasis with Snake Toxins: Molecular Mechanisms
    Félix Urra et al, 2017, Toxins CrossRef
  24. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells
    Anna Klimaszewska-Wiśniewska et al, 2018, International Journal of Molecular Sciences CrossRef
  25. Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer
    Ishwar N. Kohale et al, 2022, Cancers CrossRef
  26. Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1
    Emilie Bousquet et al, 2009, Cancer Research CrossRef
  27. Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Tzu-Hua Chang et al, 2011, American Journal of Respiratory and Critical Care Medicine CrossRef
  28. Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
    Zhiwei Wang et al, 2009, Cancer Research CrossRef
  29. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition
    Jingjing Sha et al, 2021, Biomolecules CrossRef
  30. Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways
    Pelin Ozfiliz Kilbas et al, 2020, Biology CrossRef